An Enteric Cytopathic Human Orphan virus abbreviated as echovirus is an RNA virus that causes infections and diseases of gastrointestinal tract in the human body. Primarily, infants and young children are most susceptible to echovirus however it may also infect adults leading to various diseases such as acute febrile illness, respiratory diseases, rash, hand foot and mouth disease, myocarditis, encephalitis, neonatal sepsis and aseptic meningitis. There are no specific control measures or treatments for echovirus since its spread is contagious. Yet it can be prevented through implementing good hygiene practices and avoidance of shared utensils which may interrupt transmission of the virus. Rapid diagnosis of such virus is advantageous as it may avoid unnecessary treatment with antibiotics, reduces the length of hospitalization, and eventually reduces healthcare expenses.
Globally, North America dominates the echovirus diagnostics market and is followed by Europe. Emerging countries of Asia, Middle East and Latin America are expected to drive the echovirus diagnostics market rapidly due to high rates of infections.
Some of the major factors driving the global echovirus diagnostics market include the increase in prevalence of echovirus infections in all ages due to its contagious nature, advances in molecular diagnostic technologies, bioterrorism and availability of immunosuppressive drugs in a wide range. Moreover, expansion of governmental health programs, especially in developing nations, may promote the rapid growth of echovirus diagnostics market in these regions.
Some of the major players contributing to the echovirus diagnostics market include Abbott Laboratories, Inc., Gen-Probe, Inc., Danaher Corporation, Becton Dickinson and Company, Novartis Diagnostics, Qiagen, F. Hoffmann-La Roche Ltd., Siemens Ltd., Ortho-Clinical Diagnostics, Thermo Fisher Scientific, Inc. and Wallac OY.